Ozan Ozkan

Ozan Ozkan

Auto-generated profile, based on publicly available information

Ozan Ozkan

Bioengineering Division, Hacettepe University, Beytepe, 06532, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MCMuhammet Emin Cam
Muhammet Emin Cam
AHAyse Nur Hazar-Yavuz
Ayse Nur Hazar-Yavuz
SCSumeyye Cesur
Sumeyye Cesur
OOOzan Ozkan
Ozan Ozkan
HUSSAIN ALI ALENEZIHUSSAIN ALI ALENEZI
HUSSAIN ALI ALENEZI
Mohan EdirisingheMohan Edirisinghe
Mohan Edirisinghe

7 June 2018 in IEEE Transactions on Nanobioscience
Verified
Journal Article
Closed access
ATAysenur Topsakal
Aysenur Topsakal
MUMuhammet Uzun
Muhammet Uzun
GUGaye Ugar
Gaye Ugar
AOAslihan Ozcan
Aslihan Ozcan
EAEsra Altun
Esra Altun
Oguzhan GunduzOguzhan Gunduz
Oguzhan Gunduz
Biocompatible nanocomposite electrospun fibers containing Polyurethane/Chitosan/β-Tri calcium phosphate with diverse concentrations were designed and produced through the electrospinning process for bone tissue engineering applications. After the production process, density measurement, viscosity, electrical conductivity, and tensile strength measurement tests were carried out as physical analyses of blended solutions. The chemical structural characterization was scrutinized using Fourier transform infrared spectrometer (FTIR), and scanning electron microscopy (SEM) was used to observe the morphological details of developed electrospun scaffolds. Cell viability, attachment, and proliferationwere performed using a L929 fibroblast cell line. Based on the physical, SEM, FTIR analysis, and cell culture studies, preferable nanofiber composition was selected for further studies. Amoxicillin (AMX) was loaded to that selected nanofiber composition for examination of the drug release. In comparison with other studies on similar AMX controlled products, higher drug loading and encapsulation efficiencies were obtained. It has been clearly found that the developed nanofiber composites have potential for bone tissue engineering applications.

1 April 2018 in Journal of Nanoscience and Nanotechnology
Verified
Journal Article
Closed access
OOOzan Ozkan
Ozan Ozkan
HSHilal Turkoglu Sasmazel
Hilal Turkoglu Sasmazel
In this study, antibacterial performance of the coaxially electrospun Poly-ε-caprolactone (PCL)-chitosan core–shell scaffolds developed, optimized and identified physically and chemically in our previous study, were evaluated for the suitability in wound healing applications. The aim of utilizing a core–shell fibrous scaffold with PCL as core and chitosan as shell was to combine natural biocompatibility, biodegradability and antibacterial properties of chitosan with mechanical properties and resistance to enzymatic degradation of PCL. The scaffolds were prepared with the optimized parameters, obtained from our previous study. Thickness and contact angle measurements as well as Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) analyses confirmed repeated fabrication of PCL-chitosan core–shell scaffolds. In this study, assays specific to wound dressing materials, such as water vapor transmission rate (WVTR), in vitro degradability and antibacterial tests were carried out. WVTR value of PCL-chitosan core–shell scaffolds was higher (2315 ± 3.4 g/m2 · day) compared to single PCL scaffolds (1654 ± 3.2 g/m2 · day) due to the higher inter-fiber pore size. Additionally, in vitro degradability assays showed that the susceptibility of chitosan to enzymatic degradation can be significantly improved by hybridization with more resistant PCL while still keeping the scaffold to be considered as biodegradable. Finally, inhibition ratio and inhibition zone measurements showed that the PCL-chitosan core–shell polymeric scaffolds had significant antibacterial performance (52.860 ± 2.298% and 49.333 ± 0.719% inhibition ratios; 13.975 ± 0.124 mm and 12.117 ± 0.133 mm clear inhibition zones, against E. coli and S. aureus, respectively), close to the native chitosan. Therefore, the developed scaffolds can be considered as suitable candidates for biodegradable wound dressing applications.


21 January 2020 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
ATAysenur Topsakal
Aysenur Topsakal
NENazmi Ekren
Nazmi Ekren
OKOsman Kilic
Osman Kilic
FOFaik N. Oktar
Faik N. Oktar
MMMahir Mahirogullari
Mahir Mahirogullari
Oguzhan GunduzOguzhan Gunduz
Oguzhan Gunduz

30 June 2013 in Current Tissue Engineering
Verified
Journal Article
Closed access
Hilal Turkoglu SasmazelHilal Turkoglu Sasmazel
Hilal Turkoglu Sasmazel
OOOzan Ozkan
Ozan Ozkan